erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Osteitis D010000 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Osteolysis D010014 8 associated lipids
Rhinitis D012220 10 associated lipids
Skin Ulcer D012883 6 associated lipids
Heart Diseases D006331 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Multiple Myeloma D009101 13 associated lipids
Quadriplegia D011782 4 associated lipids
Pain, Postoperative D010149 13 associated lipids
Porphyrias D011164 2 associated lipids
Femoral Fractures D005264 7 associated lipids
Hematuria D006417 13 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fractures, Open D005597 3 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Crohn Disease D003424 12 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Cholestasis D002779 23 associated lipids
Sinusitis D012852 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Nervous System Diseases D009422 37 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Cross Infection D003428 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Wound Infection D014946 12 associated lipids
Bacteriuria D001437 7 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Jones TR et al. Efficacy of an antibiotic mouthwash in contaminated head and neck surgery. 1989 Am. J. Surg. pmid:2802036
Brass C et al. The effect of metronidazole on the incidence of postoperative wound infection in elective colon surgery. 1978 Am. J. Surg. pmid:341733
LeVeen HH et al. Effects of prophylactic antibiotics on colonic healing. 1976 Am. J. Surg. pmid:1247153
Carlson RG et al. Erythromycin enhances delayed gastric emptying in dogs after Roux-Y antrectomy. 1991 Am. J. Surg. pmid:1987856
Nissan A et al. Direct inhibitory effect of erythromycin on human alimentary tract smooth muscle. 2002 Am. J. Surg. pmid:11975929
Dillon ML and Bowling KA Effect of antibiotics on wound and stool cultures. Comparison of intravenous terramycin with other antibiotics. 1967 Am. J. Surg. pmid:5334435
Nakabayashi T et al. Gastropyloric motor activity and the effects of erythromycin given orally after esophagectomy. 2002 Am. J. Surg. pmid:11943134
COHN I and LONGACRE AB Erythromycin and erythromycin-neomycin for intestinal antisepsis. 1957 Am. J. Surg. pmid:13458603
Tzovaras G et al. The effect of intravenous erythromycin on esophageal motility in healthy subjects. 1996 Am. J. Surg. pmid:8615464
Gombert ME et al. Cavitary Legionnaires' pneumonia: nosocomial infection in renal transplant recipients. 1984 Am. J. Surg. pmid:6367506
Marshall W et al. Legionnaires' disease in renal transplant patients. 1981 Am. J. Surg. pmid:7013509
Pennathur A et al. Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease. 1994 Am. J. Surg. pmid:8311129
Fry DE Colon preparation and surgical site infection. 2011 Am. J. Surg. pmid:21429471
Weaver M et al. Oral neomycin and erythromycin compared with single-dose systemic metronidazole and ceftriaxone prophylaxis in elective colorectal surgery. 1986 Am. J. Surg. pmid:3083705
Baciewicz AM and Baciewicz FA Cyclosporine pharmacokinetic drug interactions. 1989 Am. J. Surg. pmid:2644865
EICHENWALD HF and SHINEFIELD HR RATIONAL USE OF ANTIBIOTICS. 1964 Am. J. Surg. pmid:14129331
Condon RE et al. Oral neomycin and erythromycin compared with single-dose systemic metronidazole and ceftriaxone prophylaxis in elective colorectal surgery. 1986 Am. J. Surg. pmid:3777340
Vanaudenaerde BM et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. 2007 Am. J. Transplant. pmid:17061983
JUNG RC et al. Fumagillin and erythromycin in the treatment of amebiasis. 1955 Am. J. Trop. Med. Hyg. pmid:13268803
MCHARDY G et al. Erythromycin in amebiasis. 1955 Am. J. Trop. Med. Hyg. pmid:13268804
NELSON TL et al. Amebic hepatitis; laboratory findings and treatment with erythromycin. 1955 Am. J. Trop. Med. Hyg. pmid:13259005
Hamel MJ et al. Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. 2005 Am. J. Trop. Med. Hyg. pmid:16172491
NOR EL-DIN G Erythromycin in the treatment of amebiasis. 1956 Am. J. Trop. Med. Hyg. pmid:13292653
Gingras BA and Jensen JB Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. 1992 Am. J. Trop. Med. Hyg. pmid:1326232
Robins-Browne RM et al. Treatment of acute nonspecific gastroenteritis of infants and young children with erythromycin. 1983 Am. J. Trop. Med. Hyg. pmid:6349401
WILMOT AJ et al. Erythromycin in amebic liver abscess. 1958 Am. J. Trop. Med. Hyg. pmid:13595213
ANDERSON HH et al. Erythromycin stearate against systemic amebiasis in Colombia. 1955 Am. J. Trop. Med. Hyg. pmid:13238724
VILLAREJOS VM Treatment of amebiasis with erythromycin. 1955 Am. J. Trop. Med. Hyg. pmid:13238725
Kelly DJ et al. Rickettsia tsutsugamushi infection in cell culture: antibiotic susceptibility determined by flow cytometry. 1995 Am. J. Trop. Med. Hyg. pmid:8561261
ANDERSON HH et al. Antibiotic synergism in amebiasis. 1954 Am. J. Trop. Med. Hyg. pmid:13138827
Hall KA et al. Characterization of counterfeit artesunate antimalarial tablets from southeast Asia. 2006 Am. J. Trop. Med. Hyg. pmid:17123969
Gingras BA and Jensen JB Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. 1993 Am. J. Trop. Med. Hyg. pmid:8394660
MCCOWEN MC et al. The effects of erythromycin (ilotycin, lilly) against certain parasitic organisms. 1953 Am. J. Trop. Med. Hyg. pmid:13040654
Crawford KA et al. Efficacy of amoscanate against experimental schistosomal infections in monkeys. 1983 Am. J. Trop. Med. Hyg. pmid:6625061
Perine PL and Teklu B Antibiotic treatment of louse-borne relapsing fever in Ethiopia: a report of 377 cases. 1983 Am. J. Trop. Med. Hyg. pmid:6625065
Lakritz J et al. Effect of treatment with erythromycin on bronchoalveolar lavage fluid cell populations in foals. 1997 Am. J. Vet. Res. pmid:8989497
MARSHALL RT et al. THE EFFECTS OF BLOOD AND NONFAT MILK CONSTITUTENTS ON DIFFUSION OF BACTERIAL INHIBITORS IN AGAR MEDIUMS. 1964 Am. J. Vet. Res. pmid:14266843
PLASTRIDGE WN et al. ANTIBIOTIC SENSITIVITY OF PHYSIOLOGIC GROUPS OF MICROAEROPHILIC VIBRIOS. 1964 Am. J. Vet. Res. pmid:14266885
Nieto JE et al. In vitro effects of erythromycin, lidocaine, and metoclopramide on smooth muscle from the pyloric antrum, proximal portion of the duodenum, and middle portion of the jejunum of horses. 2000 Am. J. Vet. Res. pmid:10772106
Roussel AJ et al. Prokinetic effects of erythromycin on the ileum, cecum, and pelvic flexure of horses during the postoperative period. 2000 Am. J. Vet. Res. pmid:10772107
Bartlett JG et al. Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. 1978 Am. J. Vet. Res. pmid:697162
Fox JG et al. Ferret as a potential reservoir for human campylobacteriosis. 1983 Am. J. Vet. Res. pmid:6870007
Clarke CR et al. Response of Pasteurella haemolytica to erythromycin and dexamethasone in calves with established infection. 1992 Am. J. Vet. Res. pmid:1524293
Burrows GE Effects of experimentally induced Pasteurella haemolytica pneumonia on the pharmacokinetics of erythromycin in the calf. 1985 Am. J. Vet. Res. pmid:4014829
Garner HE and Coles EH Staphylococcus aureus of canine origin: bacteriophage typing and antibiotic sensitivity of cultures isolated from the nostril. 1965 Am. J. Vet. Res. pmid:5882553
Lester GD et al. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies. 1998 Am. J. Vet. Res. pmid:9522953
FLORESTANO HJ and BAHLER ME Chemotherapeutic properties of erythromycin alone and in combination with sulfamerazine. 1955 Am. J. Vet. Res. pmid:13228887
Regnery RL et al. Experimentally induced Bartonella henselae infections followed by challenge exposure and antimicrobial therapy in cats. 1996 Am. J. Vet. Res. pmid:8950424
Ringger NC et al. Effect of bethanechol or erythromycin on gastric emptying in horses. 1996 Am. J. Vet. Res. pmid:8950433
Nieto JE et al. Use of an extracorporeal circuit to evaluate effects of intraluminal distention and decompression on the equine jejunum. 2002 Am. J. Vet. Res. pmid:11843129
Palmer JE and Benson CE Effect of treatment with erythromycin and rifampin during the acute stages of experimentally induced equine ehrlichial colitis in ponies. 1992 Am. J. Vet. Res. pmid:1466503
Stalheim OH Chemotherapy of renal leptospirosis in hamsters. 1966 Am. J. Vet. Res. pmid:4164020
Lakritz J et al. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. 2000 Am. J. Vet. Res. pmid:10951982
Ramstedt KL et al. Changes in gallbladder volume in healthy dogs after food was withheld for 12 hours followed by ingestion of a meal or a meal containing erythromycin. 2008 Am. J. Vet. Res. pmid:18447796
Lakritz J et al. Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. 2000 Am. J. Vet. Res. pmid:10976728
Khan SA et al. Characterization of erythromycin-resistant methylase genes from multiple antibiotic resistant Staphylococcus spp isolated from milk samples of lactating cows. 2000 Am. J. Vet. Res. pmid:10976747
Lakritz J et al. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. 1999 Am. J. Vet. Res. pmid:10211682
Koenig JB et al. Use of multichannel electrointestinography for noninvasive assessment of myoelectrical activity in the cecum and large colon of horses. 2008 Am. J. Vet. Res. pmid:18518649
Ziv G et al. Mode of transfer of antibiotics from treated to nontreated quarters in dairy cows. 1974 Am. J. Vet. Res. pmid:4133826
Afshari GR et al. Effect of parenteral administration of ivermectin and erythromycin on abomasal emptying rate in suckling calves. 2009 Am. J. Vet. Res. pmid:19335110
Libal MC Comparison of minimal inhibitory concentration and disk-diffusion antimicrobic sensitivity testing of bacterial pathogens isolated from food animals. 1985 Am. J. Vet. Res. pmid:3159322
Cooper RF et al. Characterization of Listeria monocytogenes serotype 5. 1973 Am. J. Vet. Res. pmid:4198346
Koenig JB et al. Binding of radiolabeled porcine motilin and erythromycin lactobionate to smooth muscle membranes in various segments of the equine gastrointestinal tract. 2002 Am. J. Vet. Res. pmid:12428665
Wittek T and Constable PD Assessment of the effects of erythromycin, neostigmine, and metoclopramide on abomasal motility and emptying rate in calves. 2005 Am. J. Vet. Res. pmid:15822601
Wilson RC et al. Serum erythromycin concentration in sheep fed two diets. 1984 Am. J. Vet. Res. pmid:6742574
PEARSON CC et al. A study of the effect of three drugs on the multiplication of Anaplasma-infected bovine erythrocytes. 1962 Am. J. Vet. Res. pmid:14484757
Koenig JB et al. Effect of intraluminal distension or ischemic strangulation obstruction of the equine jejunum on jejunal motilin receptors and binding of erythromycin lactobionate. 2006 Am. J. Vet. Res. pmid:16649915
DeGeeter MJ and Stahl GL Sensitivity of Escherichia coli after exposure to lincomycin in vitro and in vivo. 1976 Am. J. Vet. Res. pmid:776050
Burrows GE et al. Serum and tissue concentrations of erythromycin in calves with induced pneumonic pasteurellosis. 1989 Am. J. Vet. Res. pmid:2774339
Smith JA et al. Inhibitory and lethal activities of rosaramicin, erythromycin, and clindamycin against Campylobacter fetus subsp jejuni and intestinalis. 1983 Am. J. Vet. Res. pmid:6625312
Kinoshita T et al. Impact of age-related alteration of plasma alpha 1-acid glycoprotein concentration on erythromycin pharmacokinetics in pigs. 1995 Am. J. Vet. Res. pmid:7771705
Nouri M and Constable PD Effect of parenteral administration of erythromycin, tilmicosin, and tylosin on abomasal emptying rate in suckling calves. 2007 Am. J. Vet. Res. pmid:18052746
Goswami SK et al. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. 1990 Am. Rev. Respir. Dis. pmid:2404441
Mukae H et al. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. 1993 Am. Rev. Respir. Dis. pmid:8103656
Ichikawa Y et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. 1992 Am. Rev. Respir. Dis. pmid:1626803
Parker MM et al. Unresponsiveness of Legionella bozemanii pneumonia to erythromycin administration despite in vitro sensitivity. 1983 Am. Rev. Respir. Dis. pmid:6638688
Datta JS and Raff MJ Actinomycotic pleuropericarditis. 1974 Am. Rev. Respir. Dis. pmid:4277986
Reisz G et al. The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis. 1983 Am. Rev. Respir. Dis. pmid:6846940
Kadota J et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. 1993 Am. Rev. Respir. Dis. pmid:8420410
Pachon J et al. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. 1990 Am. Rev. Respir. Dis. pmid:2382902
Heifets LB et al. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. 1992 Am. Rev. Respir. Dis. pmid:1532486
Ruf B et al. Acquired resistance of MAI to clarithromycin. 1992 Am. Rev. Respir. Dis. pmid:1533999
Kuperman AS and Fernandez RB Subacute staphylococcal pneumonia. 1970 Am. Rev. Respir. Dis. pmid:5410079
Finland M Pneumonia and pneumococcal infections, with special reference to pneumococcal pneumonia. The 1979 J. Burns Amberson lecture. 1979 Am. Rev. Respir. Dis. pmid:39481
Chemoprophylaxis of chronic bronchitis. A statement by the Committee on Therapy. 1971 Am. Rev. Respir. Dis. pmid:5125186
Davis SD et al. Disseminated osteomyelitis due to "Battey" mycobacteria. 1966 Am. Rev. Respir. Dis. pmid:5908093
Sakata K et al. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. 1993 Am. Rev. Respir. Dis. pmid:8214925
Edelstein PH et al. Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs. 1984 Am. Rev. Respir. Dis. pmid:6333840
Nelson S et al. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. 1987 Am. Rev. Respir. Dis. pmid:3314615
Srinivasan G et al. Branhamella catarrhalis pneumonia: report of two cases and review of the literature. 1981 Am. Rev. Respir. Dis. pmid:7235378
Hahn D Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. 1993 Am. Rev. Respir. Dis. pmid:8466109
Timberger RJ and Armstrong D Ornithosis without direct bird exposure: response to erythromycin. Report of a case. 1969 Am. Rev. Respir. Dis. pmid:5815139
Dautzenberg B et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. 1991 Am. Rev. Respir. Dis. pmid:1832527
Doyle WM et al. Pulmonary disease caused by Mycobacterium xenopei. 1968 Am. Rev. Respir. Dis. pmid:5647216
HALLETT WY et al. Chemoprophylaxis in chronic obstructive pulmonary emphysema: a twelve-week study with erythromycin. 1959 Am. Rev. Respir. Dis. pmid:14399110
MONTGOMERY CH and KNOX JM Erythromycin in the treatment of early syphilis; a preliminary report. 1959 AMA Arch Derm pmid:13669748
ROBINSON HM et al. Erythromycin in treatment of dermatoses; report on 1,695 patients. 1954 AMA Arch Derm Syphilol pmid:13188466
WOLF RL and BROWN LT Primary atypical nonbacterial pneumonia; an evaluation of the efficacy of antibiotic therapy in one hundred eighteen cases. 1956 AMA Arch Intern Med pmid:13312701
SHOEMAKER EH and YOW EM Clinical evaluation of erythromycin. 1954 AMA Arch Intern Med pmid:13123564
WADDINGTON WS et al. Treatment of bacterial pneumonia with erythromycin. 1954 AMA Arch Intern Med pmid:13137631